High level of SChLAP1 in primary GBM tumors binds to the heterogeneous nuclear ribonucleoprotein L (HNRNPL), which led to enhanced binding between HNRNPL and α-actinin-4 (ACTN4), and suppression of ACTN4 degradation. The gene discussed is HNRNPL; the disease is glioblastoma.